Literature DB >> 5576729

Anti-oestrogens and breast cancer.

L Terenius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576729     DOI: 10.1016/0014-2964(71)90095-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  10 in total

Review 1.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

2.  Letter: Breast cancer regression under oestrogen therapy.

Authors:  M L'Hermite; C Robyn; J C Heuson; M Rozencweig
Journal:  Br Med J       Date:  1974-03-02

3.  Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.

Authors:  J C Heuson; E Engelsman; J Blonk-Van Der Wijst; H Maass; A Drochmans; J Michel; H Nowakowski; A Gorins
Journal:  Br Med J       Date:  1975-06-28

4.  3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.

Authors:  G Kranzfelder; R W Hartmann; E von Angerer; H Schönenberger; A E Bogden
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

5.  Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata.

Authors:  W Powell-Jones; D A Jenner; R W Blamey; P Davies; K Griffiths
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

Review 6.  Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 7.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

8.  Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.

Authors:  J Kocsis; G Karácsony; S Karcsú; F A László
Journal:  Br J Exp Pathol       Date:  1988-04

Review 9.  Tamoxifen: catalyst for the change to targeted therapy.

Authors:  V Craig Jordan
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

10.  Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.

Authors:  H J Bloom; E Boesen
Journal:  Br Med J       Date:  1974-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.